The investigation of drug withdrawal with immunosuppressant and biologics for ulcerative colitis patients

The investigation of drug withdrawal with immunosuppressant and biologics for ulcerative colitis patients - The investigation of drug withdrawal for ulcerative colitis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009678

Enrollment

Registered

2013-01-15

Start date

2013-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients of ulcerative colitis who are maintained by using biologics and/or immunosuppressant, and who are diagnosed as clinical remission and confirmed as mucosal healing by endoscopy. All patients should be agreed the burden of this study.

Exclusion criteria

Exclusion criteria: The patients who are impaired consciousness and do not have the ability of agreement.

Design outcomes

Primary

Measure	Time frame
Endoscopic findings for 12, 24, 36 months from the start of this study.	—

Secondary

Measure	Time frame
Clinical activity index (CAI) for every 3 month from the start of this study.	—

Countries

Japan

Contacts

Public ContactTomohisa Takagi

Kyoto Prefectural University of Medicine Molecular Gastroenterology and Hepatology

takatomo@koto.kpu-m.ac.jp075-251-5519

Outcome results